GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (ROCO:4743) » Definitions » EPS (Basic)

Oneness Biotech Co (ROCO:4743) EPS (Basic) : NT$-2.56 (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Oneness Biotech Co EPS (Basic)?

Oneness Biotech Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$-0.34. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2.56.

Oneness Biotech Co's EPS (Diluted) for the three months ended in Mar. 2025 was NT$-0.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2.56.

Oneness Biotech Co's EPS without NRI for the three months ended in Mar. 2025 was NT$-0.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -2.56.

During the past 3 years, the average EPS without NRI Growth Rate was -40.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Oneness Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 117.10% per year. The lowest was -164.00% per year. And the median was -33.90% per year.


Oneness Biotech Co EPS (Basic) Historical Data

The historical data trend for Oneness Biotech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co EPS (Basic) Chart

Oneness Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.57 -0.88 0.78 -2.77 -2.44

Oneness Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.34 -1.06 -0.82 -0.34

Oneness Biotech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Oneness Biotech Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1165.147-0)/478.183
=-2.44

Oneness Biotech Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-162.321-0)/479.206
=-0.34

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oneness Biotech Co  (ROCO:4743) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Oneness Biotech Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Section. 1, Zhongxiao West Road, No. 66, 35th Floor, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The company's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, OB318, and others. Along with its subsidiaries, the company operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation segment.

Oneness Biotech Co Headlines

No Headlines